4
Changes in Ownership
Cogent Biosciences, Inc. Filed Acc 0001209191-19-021324
Chief Scientific Officer sold 11,485 shares at $4.12 ($47,334)
- Chief Scientific Officer acquired 11,485 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ettenberg Seth Chief Scientific Officer | 2019-03-25 | Option exercise | +11,485 | $0.18 | $2,067 | 11,485 | D: show line 1 in the form |
| Ettenberg Seth Chief Scientific Officer | 2019-03-25 | Sale | −11,485 | $4.12 | $47,334 | 0 | D: show line 2 in the form |
| Open-market sales · 11,485 sh · avg $4.12 · $47,334 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ettenberg Seth Chief Scientific Officer | 2019-03-25 | Grant or award · Stock Option (Right to Buy) | +11,485 | 329,145 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…